Arcus Biosciences, Inc.

NYSE:RCUS

Biotechnology

Healthcare
$15.78 -0.39%

-$0.09 today

Market cap
$2.27B
Beta
0.84
P/E (TTM)
-8.2
EPS (TTM)
-$2.94
52W Low $7.91High $28.72

Volume 1.07M

Average 1.17M

Income Statement

Follow revenue through to earnings.

Revenue

$247.00M

FY 2025 · Annual

-4.3% YoY

Operating Income

-$386.00M

FY 2025 · Annual

Net Income

-$353.00M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue383M112M117M258M247M
Cost of Revenue000010M
Gross Profit383M112M117M258M237M
Gross Margin100.0%100.0%100.0%100.0%96.0%
Research & Development257M288M340M448M523M
Selling, General & Admin72M104M117M120M110M
Operating Expenses329M392M457M588M623M
Depreciation & Amortization4M6M8M10M10M
EBITDA59M(258M)(291M)(269M)(335M)
EBITDA Margin15.4%-230.4%-248.7%-104.3%-135.6%
Operating Income54M(280M)(340M)(330M)(386M)
Operating Margin14.1%-250.0%-290.6%-127.9%-156.3%
Interest Income1M16M41M52M41M
Interest Expense02M2M4M8M
Other Income / Expenses1M14M39M47M33M
Income Before Tax55M(266M)(301M)(283M)(353M)
Pre-Tax Margin14.4%-237.5%-257.3%-109.7%-142.9%
Income Tax Expense2M1M6M1M0
Net Income53M(267M)(307M)(283M)(353M)
Net Margin13.8%-238.4%-262.4%-109.7%-142.9%
EPS (Basic)0.76(3.71)(4.15)(3.14)(3.29)
EPS (Diluted)0.71(3.71)(4.15)(3.14)(3.29)
Weighted Avg Shares69.35M72M74M90.1M107.4M
Weighted Avg Shares (Diluted)73.97M72M74M90.1M107.4M

RCUS Earnings Waterfall · TTM

NYSE:RCUS · Revenue to Net Income

Key Ratios

EPS$-3.93
Gross Margin92.9%
Net Margin-447.8%
P/E Ratio-6.3
P/S Ratio96.9

Analysis

$117.0M of revenue converted into -$452.0M of net income for the selected period. Gross margin is 92.9% and net margin is -447.8%, showing how much revenue survives after costs and taxes. EPS is $-3.93, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 4, 2026
8-KCurrent reportNov 4, 2026
8-KCurrent reportOct 23, 2026
424B5424B5 filingOct 22, 2026
8-KCurrent reportOct 21, 2026

How much revenue does RCUS generate?

Arcus Biosciences, Inc. (RCUS) reported $247.00M of revenue in fiscal 2025.

Is RCUS profitable?

Arcus Biosciences, Inc. (RCUS) reported -$353.00M of net income, with a net margin of -142.9%.